Global Budesonide Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Budesonide market size is predicted to grow from US$ 8788 million in 2025 to US$ 10690 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn"s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
LP Information, Inc. (LPI) ' newest research report, the “Budesonide Industry Forecast” looks at past sales and reviews total world Budesonide sales in 2024, providing a comprehensive analysis by region and market sector of projected Budesonide sales for 2025 through 2031. With Budesonide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Budesonide industry.
This Insight Report provides a comprehensive analysis of the global Budesonide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Budesonide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Budesonide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Budesonide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Budesonide.
This report presents a comprehensive overview, market shares, and growth opportunities of Budesonide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Budesonide market?
What factors are driving Budesonide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Budesonide market opportunities vary by end market size?
How does Budesonide break out by Type, by Application?
The global Budesonide market size is predicted to grow from US$ 8788 million in 2025 to US$ 10690 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn"s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
LP Information, Inc. (LPI) ' newest research report, the “Budesonide Industry Forecast” looks at past sales and reviews total world Budesonide sales in 2024, providing a comprehensive analysis by region and market sector of projected Budesonide sales for 2025 through 2031. With Budesonide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Budesonide industry.
This Insight Report provides a comprehensive analysis of the global Budesonide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Budesonide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Budesonide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Budesonide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Budesonide.
This report presents a comprehensive overview, market shares, and growth opportunities of Budesonide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injectable Suspension
- Aerosols
- Inhalation Powder
- Tablet and Capsule
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Teva
- Mylan
- Sandoz
- Cosmo Pharmaceuticals
- Salix
- Chiesi Farmaceutici
- Orion Corporation
- Cipla
- Synmosa Biopharma
- Lunan Better Pharma
- Shanghai Sine Promod
What is the 10-year outlook for the global Budesonide market?
What factors are driving Budesonide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Budesonide market opportunities vary by end market size?
How does Budesonide break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Budesonide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Budesonide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Budesonide by Country/Region, 2020, 2024 & 2031
2.2 Budesonide Segment by Type
2.2.1 Injectable Suspension
2.2.2 Aerosols
2.2.3 Inhalation Powder
2.2.4 Tablet and Capsule
2.3 Budesonide Sales by Type
2.3.1 Global Budesonide Sales Market Share by Type (2020-2025)
2.3.2 Global Budesonide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Budesonide Sale Price by Type (2020-2025)
2.4 Budesonide Segment by Application
2.4.1 Respiratory Disease Treatment
2.4.2 Nose Disease Treatment
2.4.3 Inflammatory Bowel Disease Treatment
2.4.4 Others
2.5 Budesonide Sales by Application
2.5.1 Global Budesonide Sale Market Share by Application (2020-2025)
2.5.2 Global Budesonide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Budesonide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Budesonide Breakdown Data by Company
3.1.1 Global Budesonide Annual Sales by Company (2020-2025)
3.1.2 Global Budesonide Sales Market Share by Company (2020-2025)
3.2 Global Budesonide Annual Revenue by Company (2020-2025)
3.2.1 Global Budesonide Revenue by Company (2020-2025)
3.2.2 Global Budesonide Revenue Market Share by Company (2020-2025)
3.3 Global Budesonide Sale Price by Company
3.4 Key Manufacturers Budesonide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Budesonide Product Location Distribution
3.4.2 Players Budesonide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BUDESONIDE BY GEOGRAPHIC REGION
4.1 World Historic Budesonide Market Size by Geographic Region (2020-2025)
4.1.1 Global Budesonide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Budesonide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Budesonide Market Size by Country/Region (2020-2025)
4.2.1 Global Budesonide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Budesonide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Budesonide Sales Growth
4.4 APAC Budesonide Sales Growth
4.5 Europe Budesonide Sales Growth
4.6 Middle East & Africa Budesonide Sales Growth
5 AMERICAS
5.1 Americas Budesonide Sales by Country
5.1.1 Americas Budesonide Sales by Country (2020-2025)
5.1.2 Americas Budesonide Revenue by Country (2020-2025)
5.2 Americas Budesonide Sales by Type (2020-2025)
5.3 Americas Budesonide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Budesonide Sales by Region
6.1.1 APAC Budesonide Sales by Region (2020-2025)
6.1.2 APAC Budesonide Revenue by Region (2020-2025)
6.2 APAC Budesonide Sales by Type (2020-2025)
6.3 APAC Budesonide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Budesonide by Country
7.1.1 Europe Budesonide Sales by Country (2020-2025)
7.1.2 Europe Budesonide Revenue by Country (2020-2025)
7.2 Europe Budesonide Sales by Type (2020-2025)
7.3 Europe Budesonide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Budesonide by Country
8.1.1 Middle East & Africa Budesonide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Budesonide Revenue by Country (2020-2025)
8.2 Middle East & Africa Budesonide Sales by Type (2020-2025)
8.3 Middle East & Africa Budesonide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Budesonide
10.3 Manufacturing Process Analysis of Budesonide
10.4 Industry Chain Structure of Budesonide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Budesonide Distributors
11.3 Budesonide Customer
12 WORLD FORECAST REVIEW FOR BUDESONIDE BY GEOGRAPHIC REGION
12.1 Global Budesonide Market Size Forecast by Region
12.1.1 Global Budesonide Forecast by Region (2026-2031)
12.1.2 Global Budesonide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Budesonide Forecast by Type (2026-2031)
12.7 Global Budesonide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Budesonide Product Portfolios and Specifications
13.1.3 AstraZeneca Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Budesonide Product Portfolios and Specifications
13.2.3 Teva Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Budesonide Product Portfolios and Specifications
13.3.3 Mylan Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Budesonide Product Portfolios and Specifications
13.4.3 Sandoz Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Cosmo Pharmaceuticals
13.5.1 Cosmo Pharmaceuticals Company Information
13.5.2 Cosmo Pharmaceuticals Budesonide Product Portfolios and Specifications
13.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cosmo Pharmaceuticals Main Business Overview
13.5.5 Cosmo Pharmaceuticals Latest Developments
13.6 Salix
13.6.1 Salix Company Information
13.6.2 Salix Budesonide Product Portfolios and Specifications
13.6.3 Salix Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Salix Main Business Overview
13.6.5 Salix Latest Developments
13.7 Chiesi Farmaceutici
13.7.1 Chiesi Farmaceutici Company Information
13.7.2 Chiesi Farmaceutici Budesonide Product Portfolios and Specifications
13.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Chiesi Farmaceutici Main Business Overview
13.7.5 Chiesi Farmaceutici Latest Developments
13.8 Orion Corporation
13.8.1 Orion Corporation Company Information
13.8.2 Orion Corporation Budesonide Product Portfolios and Specifications
13.8.3 Orion Corporation Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Orion Corporation Main Business Overview
13.8.5 Orion Corporation Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Budesonide Product Portfolios and Specifications
13.9.3 Cipla Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Synmosa Biopharma
13.10.1 Synmosa Biopharma Company Information
13.10.2 Synmosa Biopharma Budesonide Product Portfolios and Specifications
13.10.3 Synmosa Biopharma Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Synmosa Biopharma Main Business Overview
13.10.5 Synmosa Biopharma Latest Developments
13.11 Lunan Better Pharma
13.11.1 Lunan Better Pharma Company Information
13.11.2 Lunan Better Pharma Budesonide Product Portfolios and Specifications
13.11.3 Lunan Better Pharma Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lunan Better Pharma Main Business Overview
13.11.5 Lunan Better Pharma Latest Developments
13.12 Shanghai Sine Promod
13.12.1 Shanghai Sine Promod Company Information
13.12.2 Shanghai Sine Promod Budesonide Product Portfolios and Specifications
13.12.3 Shanghai Sine Promod Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shanghai Sine Promod Main Business Overview
13.12.5 Shanghai Sine Promod Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Budesonide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Budesonide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Budesonide by Country/Region, 2020, 2024 & 2031
2.2 Budesonide Segment by Type
2.2.1 Injectable Suspension
2.2.2 Aerosols
2.2.3 Inhalation Powder
2.2.4 Tablet and Capsule
2.3 Budesonide Sales by Type
2.3.1 Global Budesonide Sales Market Share by Type (2020-2025)
2.3.2 Global Budesonide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Budesonide Sale Price by Type (2020-2025)
2.4 Budesonide Segment by Application
2.4.1 Respiratory Disease Treatment
2.4.2 Nose Disease Treatment
2.4.3 Inflammatory Bowel Disease Treatment
2.4.4 Others
2.5 Budesonide Sales by Application
2.5.1 Global Budesonide Sale Market Share by Application (2020-2025)
2.5.2 Global Budesonide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Budesonide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Budesonide Breakdown Data by Company
3.1.1 Global Budesonide Annual Sales by Company (2020-2025)
3.1.2 Global Budesonide Sales Market Share by Company (2020-2025)
3.2 Global Budesonide Annual Revenue by Company (2020-2025)
3.2.1 Global Budesonide Revenue by Company (2020-2025)
3.2.2 Global Budesonide Revenue Market Share by Company (2020-2025)
3.3 Global Budesonide Sale Price by Company
3.4 Key Manufacturers Budesonide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Budesonide Product Location Distribution
3.4.2 Players Budesonide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BUDESONIDE BY GEOGRAPHIC REGION
4.1 World Historic Budesonide Market Size by Geographic Region (2020-2025)
4.1.1 Global Budesonide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Budesonide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Budesonide Market Size by Country/Region (2020-2025)
4.2.1 Global Budesonide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Budesonide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Budesonide Sales Growth
4.4 APAC Budesonide Sales Growth
4.5 Europe Budesonide Sales Growth
4.6 Middle East & Africa Budesonide Sales Growth
5 AMERICAS
5.1 Americas Budesonide Sales by Country
5.1.1 Americas Budesonide Sales by Country (2020-2025)
5.1.2 Americas Budesonide Revenue by Country (2020-2025)
5.2 Americas Budesonide Sales by Type (2020-2025)
5.3 Americas Budesonide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Budesonide Sales by Region
6.1.1 APAC Budesonide Sales by Region (2020-2025)
6.1.2 APAC Budesonide Revenue by Region (2020-2025)
6.2 APAC Budesonide Sales by Type (2020-2025)
6.3 APAC Budesonide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Budesonide by Country
7.1.1 Europe Budesonide Sales by Country (2020-2025)
7.1.2 Europe Budesonide Revenue by Country (2020-2025)
7.2 Europe Budesonide Sales by Type (2020-2025)
7.3 Europe Budesonide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Budesonide by Country
8.1.1 Middle East & Africa Budesonide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Budesonide Revenue by Country (2020-2025)
8.2 Middle East & Africa Budesonide Sales by Type (2020-2025)
8.3 Middle East & Africa Budesonide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Budesonide
10.3 Manufacturing Process Analysis of Budesonide
10.4 Industry Chain Structure of Budesonide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Budesonide Distributors
11.3 Budesonide Customer
12 WORLD FORECAST REVIEW FOR BUDESONIDE BY GEOGRAPHIC REGION
12.1 Global Budesonide Market Size Forecast by Region
12.1.1 Global Budesonide Forecast by Region (2026-2031)
12.1.2 Global Budesonide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Budesonide Forecast by Type (2026-2031)
12.7 Global Budesonide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Budesonide Product Portfolios and Specifications
13.1.3 AstraZeneca Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Budesonide Product Portfolios and Specifications
13.2.3 Teva Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Budesonide Product Portfolios and Specifications
13.3.3 Mylan Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Budesonide Product Portfolios and Specifications
13.4.3 Sandoz Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Cosmo Pharmaceuticals
13.5.1 Cosmo Pharmaceuticals Company Information
13.5.2 Cosmo Pharmaceuticals Budesonide Product Portfolios and Specifications
13.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cosmo Pharmaceuticals Main Business Overview
13.5.5 Cosmo Pharmaceuticals Latest Developments
13.6 Salix
13.6.1 Salix Company Information
13.6.2 Salix Budesonide Product Portfolios and Specifications
13.6.3 Salix Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Salix Main Business Overview
13.6.5 Salix Latest Developments
13.7 Chiesi Farmaceutici
13.7.1 Chiesi Farmaceutici Company Information
13.7.2 Chiesi Farmaceutici Budesonide Product Portfolios and Specifications
13.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Chiesi Farmaceutici Main Business Overview
13.7.5 Chiesi Farmaceutici Latest Developments
13.8 Orion Corporation
13.8.1 Orion Corporation Company Information
13.8.2 Orion Corporation Budesonide Product Portfolios and Specifications
13.8.3 Orion Corporation Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Orion Corporation Main Business Overview
13.8.5 Orion Corporation Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Budesonide Product Portfolios and Specifications
13.9.3 Cipla Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 Synmosa Biopharma
13.10.1 Synmosa Biopharma Company Information
13.10.2 Synmosa Biopharma Budesonide Product Portfolios and Specifications
13.10.3 Synmosa Biopharma Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Synmosa Biopharma Main Business Overview
13.10.5 Synmosa Biopharma Latest Developments
13.11 Lunan Better Pharma
13.11.1 Lunan Better Pharma Company Information
13.11.2 Lunan Better Pharma Budesonide Product Portfolios and Specifications
13.11.3 Lunan Better Pharma Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lunan Better Pharma Main Business Overview
13.11.5 Lunan Better Pharma Latest Developments
13.12 Shanghai Sine Promod
13.12.1 Shanghai Sine Promod Company Information
13.12.2 Shanghai Sine Promod Budesonide Product Portfolios and Specifications
13.12.3 Shanghai Sine Promod Budesonide Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shanghai Sine Promod Main Business Overview
13.12.5 Shanghai Sine Promod Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Budesonide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Budesonide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injectable Suspension
Table 4. Major Players of Aerosols
Table 5. Major Players of Inhalation Powder
Table 6. Major Players of Tablet and Capsule
Table 7. Global Budesonide Sales by Type (2020-2025) & (M Units)
Table 8. Global Budesonide Sales Market Share by Type (2020-2025)
Table 9. Global Budesonide Revenue by Type (2020-2025) & ($ million)
Table 10. Global Budesonide Revenue Market Share by Type (2020-2025)
Table 11. Global Budesonide Sale Price by Type (2020-2025) & (USD/K Units)
Table 12. Global Budesonide Sale by Application (2020-2025) & (M Units)
Table 13. Global Budesonide Sale Market Share by Application (2020-2025)
Table 14. Global Budesonide Revenue by Application (2020-2025) & ($ million)
Table 15. Global Budesonide Revenue Market Share by Application (2020-2025)
Table 16. Global Budesonide Sale Price by Application (2020-2025) & (USD/K Units)
Table 17. Global Budesonide Sales by Company (2020-2025) & (M Units)
Table 18. Global Budesonide Sales Market Share by Company (2020-2025)
Table 19. Global Budesonide Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Budesonide Revenue Market Share by Company (2020-2025)
Table 21. Global Budesonide Sale Price by Company (2020-2025) & (USD/K Units)
Table 22. Key Manufacturers Budesonide Producing Area Distribution and Sales Area
Table 23. Players Budesonide Products Offered
Table 24. Budesonide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Budesonide Sales by Geographic Region (2020-2025) & (M Units)
Table 28. Global Budesonide Sales Market Share Geographic Region (2020-2025)
Table 29. Global Budesonide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Budesonide Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Budesonide Sales by Country/Region (2020-2025) & (M Units)
Table 32. Global Budesonide Sales Market Share by Country/Region (2020-2025)
Table 33. Global Budesonide Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Budesonide Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Budesonide Sales by Country (2020-2025) & (M Units)
Table 36. Americas Budesonide Sales Market Share by Country (2020-2025)
Table 37. Americas Budesonide Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Budesonide Sales by Type (2020-2025) & (M Units)
Table 39. Americas Budesonide Sales by Application (2020-2025) & (M Units)
Table 40. APAC Budesonide Sales by Region (2020-2025) & (M Units)
Table 41. APAC Budesonide Sales Market Share by Region (2020-2025)
Table 42. APAC Budesonide Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Budesonide Sales by Type (2020-2025) & (M Units)
Table 44. APAC Budesonide Sales by Application (2020-2025) & (M Units)
Table 45. Europe Budesonide Sales by Country (2020-2025) & (M Units)
Table 46. Europe Budesonide Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Budesonide Sales by Type (2020-2025) & (M Units)
Table 48. Europe Budesonide Sales by Application (2020-2025) & (M Units)
Table 49. Middle East & Africa Budesonide Sales by Country (2020-2025) & (M Units)
Table 50. Middle East & Africa Budesonide Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Budesonide Sales by Type (2020-2025) & (M Units)
Table 52. Middle East & Africa Budesonide Sales by Application (2020-2025) & (M Units)
Table 53. Key Market Drivers & Growth Opportunities of Budesonide
Table 54. Key Market Challenges & Risks of Budesonide
Table 55. Key Industry Trends of Budesonide
Table 56. Budesonide Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Budesonide Distributors List
Table 59. Budesonide Customer List
Table 60. Global Budesonide Sales Forecast by Region (2026-2031) & (M Units)
Table 61. Global Budesonide Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Budesonide Sales Forecast by Country (2026-2031) & (M Units)
Table 63. Americas Budesonide Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Budesonide Sales Forecast by Region (2026-2031) & (M Units)
Table 65. APAC Budesonide Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Budesonide Sales Forecast by Country (2026-2031) & (M Units)
Table 67. Europe Budesonide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Budesonide Sales Forecast by Country (2026-2031) & (M Units)
Table 69. Middle East & Africa Budesonide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Budesonide Sales Forecast by Type (2026-2031) & (M Units)
Table 71. Global Budesonide Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Budesonide Sales Forecast by Application (2026-2031) & (M Units)
Table 73. Global Budesonide Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. AstraZeneca Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 75. AstraZeneca Budesonide Product Portfolios and Specifications
Table 76. AstraZeneca Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 77. AstraZeneca Main Business
Table 78. AstraZeneca Latest Developments
Table 79. Teva Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva Budesonide Product Portfolios and Specifications
Table 81. Teva Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Mylan Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Budesonide Product Portfolios and Specifications
Table 86. Mylan Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Sandoz Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 90. Sandoz Budesonide Product Portfolios and Specifications
Table 91. Sandoz Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 92. Sandoz Main Business
Table 93. Sandoz Latest Developments
Table 94. Cosmo Pharmaceuticals Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 95. Cosmo Pharmaceuticals Budesonide Product Portfolios and Specifications
Table 96. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 97. Cosmo Pharmaceuticals Main Business
Table 98. Cosmo Pharmaceuticals Latest Developments
Table 99. Salix Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 100. Salix Budesonide Product Portfolios and Specifications
Table 101. Salix Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 102. Salix Main Business
Table 103. Salix Latest Developments
Table 104. Chiesi Farmaceutici Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 105. Chiesi Farmaceutici Budesonide Product Portfolios and Specifications
Table 106. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 107. Chiesi Farmaceutici Main Business
Table 108. Chiesi Farmaceutici Latest Developments
Table 109. Orion Corporation Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 110. Orion Corporation Budesonide Product Portfolios and Specifications
Table 111. Orion Corporation Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 112. Orion Corporation Main Business
Table 113. Orion Corporation Latest Developments
Table 114. Cipla Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 115. Cipla Budesonide Product Portfolios and Specifications
Table 116. Cipla Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 117. Cipla Main Business
Table 118. Cipla Latest Developments
Table 119. Synmosa Biopharma Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 120. Synmosa Biopharma Budesonide Product Portfolios and Specifications
Table 121. Synmosa Biopharma Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 122. Synmosa Biopharma Main Business
Table 123. Synmosa Biopharma Latest Developments
Table 124. Lunan Better Pharma Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 125. Lunan Better Pharma Budesonide Product Portfolios and Specifications
Table 126. Lunan Better Pharma Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 127. Lunan Better Pharma Main Business
Table 128. Lunan Better Pharma Latest Developments
Table 129. Shanghai Sine Promod Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 130. Shanghai Sine Promod Budesonide Product Portfolios and Specifications
Table 131. Shanghai Sine Promod Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 132. Shanghai Sine Promod Main Business
Table 133. Shanghai Sine Promod Latest Developments
Table 1. Budesonide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Budesonide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injectable Suspension
Table 4. Major Players of Aerosols
Table 5. Major Players of Inhalation Powder
Table 6. Major Players of Tablet and Capsule
Table 7. Global Budesonide Sales by Type (2020-2025) & (M Units)
Table 8. Global Budesonide Sales Market Share by Type (2020-2025)
Table 9. Global Budesonide Revenue by Type (2020-2025) & ($ million)
Table 10. Global Budesonide Revenue Market Share by Type (2020-2025)
Table 11. Global Budesonide Sale Price by Type (2020-2025) & (USD/K Units)
Table 12. Global Budesonide Sale by Application (2020-2025) & (M Units)
Table 13. Global Budesonide Sale Market Share by Application (2020-2025)
Table 14. Global Budesonide Revenue by Application (2020-2025) & ($ million)
Table 15. Global Budesonide Revenue Market Share by Application (2020-2025)
Table 16. Global Budesonide Sale Price by Application (2020-2025) & (USD/K Units)
Table 17. Global Budesonide Sales by Company (2020-2025) & (M Units)
Table 18. Global Budesonide Sales Market Share by Company (2020-2025)
Table 19. Global Budesonide Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Budesonide Revenue Market Share by Company (2020-2025)
Table 21. Global Budesonide Sale Price by Company (2020-2025) & (USD/K Units)
Table 22. Key Manufacturers Budesonide Producing Area Distribution and Sales Area
Table 23. Players Budesonide Products Offered
Table 24. Budesonide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Budesonide Sales by Geographic Region (2020-2025) & (M Units)
Table 28. Global Budesonide Sales Market Share Geographic Region (2020-2025)
Table 29. Global Budesonide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Budesonide Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Budesonide Sales by Country/Region (2020-2025) & (M Units)
Table 32. Global Budesonide Sales Market Share by Country/Region (2020-2025)
Table 33. Global Budesonide Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Budesonide Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Budesonide Sales by Country (2020-2025) & (M Units)
Table 36. Americas Budesonide Sales Market Share by Country (2020-2025)
Table 37. Americas Budesonide Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Budesonide Sales by Type (2020-2025) & (M Units)
Table 39. Americas Budesonide Sales by Application (2020-2025) & (M Units)
Table 40. APAC Budesonide Sales by Region (2020-2025) & (M Units)
Table 41. APAC Budesonide Sales Market Share by Region (2020-2025)
Table 42. APAC Budesonide Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Budesonide Sales by Type (2020-2025) & (M Units)
Table 44. APAC Budesonide Sales by Application (2020-2025) & (M Units)
Table 45. Europe Budesonide Sales by Country (2020-2025) & (M Units)
Table 46. Europe Budesonide Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Budesonide Sales by Type (2020-2025) & (M Units)
Table 48. Europe Budesonide Sales by Application (2020-2025) & (M Units)
Table 49. Middle East & Africa Budesonide Sales by Country (2020-2025) & (M Units)
Table 50. Middle East & Africa Budesonide Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Budesonide Sales by Type (2020-2025) & (M Units)
Table 52. Middle East & Africa Budesonide Sales by Application (2020-2025) & (M Units)
Table 53. Key Market Drivers & Growth Opportunities of Budesonide
Table 54. Key Market Challenges & Risks of Budesonide
Table 55. Key Industry Trends of Budesonide
Table 56. Budesonide Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Budesonide Distributors List
Table 59. Budesonide Customer List
Table 60. Global Budesonide Sales Forecast by Region (2026-2031) & (M Units)
Table 61. Global Budesonide Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Budesonide Sales Forecast by Country (2026-2031) & (M Units)
Table 63. Americas Budesonide Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Budesonide Sales Forecast by Region (2026-2031) & (M Units)
Table 65. APAC Budesonide Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Budesonide Sales Forecast by Country (2026-2031) & (M Units)
Table 67. Europe Budesonide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Budesonide Sales Forecast by Country (2026-2031) & (M Units)
Table 69. Middle East & Africa Budesonide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Budesonide Sales Forecast by Type (2026-2031) & (M Units)
Table 71. Global Budesonide Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Budesonide Sales Forecast by Application (2026-2031) & (M Units)
Table 73. Global Budesonide Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. AstraZeneca Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 75. AstraZeneca Budesonide Product Portfolios and Specifications
Table 76. AstraZeneca Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 77. AstraZeneca Main Business
Table 78. AstraZeneca Latest Developments
Table 79. Teva Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva Budesonide Product Portfolios and Specifications
Table 81. Teva Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Mylan Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Budesonide Product Portfolios and Specifications
Table 86. Mylan Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Sandoz Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 90. Sandoz Budesonide Product Portfolios and Specifications
Table 91. Sandoz Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 92. Sandoz Main Business
Table 93. Sandoz Latest Developments
Table 94. Cosmo Pharmaceuticals Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 95. Cosmo Pharmaceuticals Budesonide Product Portfolios and Specifications
Table 96. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 97. Cosmo Pharmaceuticals Main Business
Table 98. Cosmo Pharmaceuticals Latest Developments
Table 99. Salix Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 100. Salix Budesonide Product Portfolios and Specifications
Table 101. Salix Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 102. Salix Main Business
Table 103. Salix Latest Developments
Table 104. Chiesi Farmaceutici Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 105. Chiesi Farmaceutici Budesonide Product Portfolios and Specifications
Table 106. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 107. Chiesi Farmaceutici Main Business
Table 108. Chiesi Farmaceutici Latest Developments
Table 109. Orion Corporation Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 110. Orion Corporation Budesonide Product Portfolios and Specifications
Table 111. Orion Corporation Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 112. Orion Corporation Main Business
Table 113. Orion Corporation Latest Developments
Table 114. Cipla Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 115. Cipla Budesonide Product Portfolios and Specifications
Table 116. Cipla Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 117. Cipla Main Business
Table 118. Cipla Latest Developments
Table 119. Synmosa Biopharma Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 120. Synmosa Biopharma Budesonide Product Portfolios and Specifications
Table 121. Synmosa Biopharma Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 122. Synmosa Biopharma Main Business
Table 123. Synmosa Biopharma Latest Developments
Table 124. Lunan Better Pharma Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 125. Lunan Better Pharma Budesonide Product Portfolios and Specifications
Table 126. Lunan Better Pharma Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 127. Lunan Better Pharma Main Business
Table 128. Lunan Better Pharma Latest Developments
Table 129. Shanghai Sine Promod Basic Information, Budesonide Manufacturing Base, Sales Area and Its Competitors
Table 130. Shanghai Sine Promod Budesonide Product Portfolios and Specifications
Table 131. Shanghai Sine Promod Budesonide Sales (M Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 132. Shanghai Sine Promod Main Business
Table 133. Shanghai Sine Promod Latest Developments
LIST OF FIGURES
Figure 1. Picture of Budesonide
Figure 2. Budesonide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Budesonide Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Budesonide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Budesonide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Budesonide Sales Market Share by Country/Region (2024)
Figure 10. Budesonide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injectable Suspension
Figure 12. Product Picture of Aerosols
Figure 13. Product Picture of Inhalation Powder
Figure 14. Product Picture of Tablet and Capsule
Figure 15. Global Budesonide Sales Market Share by Type in 2025
Figure 16. Global Budesonide Revenue Market Share by Type (2020-2025)
Figure 17. Budesonide Consumed in Respiratory Disease Treatment
Figure 18. Global Budesonide Market: Respiratory Disease Treatment (2020-2025) & (M Units)
Figure 19. Budesonide Consumed in Nose Disease Treatment
Figure 20. Global Budesonide Market: Nose Disease Treatment (2020-2025) & (M Units)
Figure 21. Budesonide Consumed in Inflammatory Bowel Disease Treatment
Figure 22. Global Budesonide Market: Inflammatory Bowel Disease Treatment (2020-2025) & (M Units)
Figure 23. Budesonide Consumed in Others
Figure 24. Global Budesonide Market: Others (2020-2025) & (M Units)
Figure 25. Global Budesonide Sale Market Share by Application (2024)
Figure 26. Global Budesonide Revenue Market Share by Application in 2025
Figure 27. Budesonide Sales by Company in 2025 (M Units)
Figure 28. Global Budesonide Sales Market Share by Company in 2025
Figure 29. Budesonide Revenue by Company in 2025 ($ millions)
Figure 30. Global Budesonide Revenue Market Share by Company in 2025
Figure 31. Global Budesonide Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Budesonide Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Budesonide Sales 2020-2025 (M Units)
Figure 34. Americas Budesonide Revenue 2020-2025 ($ millions)
Figure 35. APAC Budesonide Sales 2020-2025 (M Units)
Figure 36. APAC Budesonide Revenue 2020-2025 ($ millions)
Figure 37. Europe Budesonide Sales 2020-2025 (M Units)
Figure 38. Europe Budesonide Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Budesonide Sales 2020-2025 (M Units)
Figure 40. Middle East & Africa Budesonide Revenue 2020-2025 ($ millions)
Figure 41. Americas Budesonide Sales Market Share by Country in 2025
Figure 42. Americas Budesonide Revenue Market Share by Country (2020-2025)
Figure 43. Americas Budesonide Sales Market Share by Type (2020-2025)
Figure 44. Americas Budesonide Sales Market Share by Application (2020-2025)
Figure 45. United States Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Budesonide Sales Market Share by Region in 2025
Figure 50. APAC Budesonide Revenue Market Share by Region (2020-2025)
Figure 51. APAC Budesonide Sales Market Share by Type (2020-2025)
Figure 52. APAC Budesonide Sales Market Share by Application (2020-2025)
Figure 53. China Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 57. India Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Budesonide Sales Market Share by Country in 2025
Figure 61. Europe Budesonide Revenue Market Share by Country (2020-2025)
Figure 62. Europe Budesonide Sales Market Share by Type (2020-2025)
Figure 63. Europe Budesonide Sales Market Share by Application (2020-2025)
Figure 64. Germany Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 65. France Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Budesonide Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Budesonide Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Budesonide Sales Market Share by Application (2020-2025)
Figure 72. Egypt Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Budesonide in 2025
Figure 78. Manufacturing Process Analysis of Budesonide
Figure 79. Industry Chain Structure of Budesonide
Figure 80. Channels of Distribution
Figure 81. Global Budesonide Sales Market Forecast by Region (2026-2031)
Figure 82. Global Budesonide Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Budesonide Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Budesonide Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Budesonide Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Budesonide Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Budesonide
Figure 2. Budesonide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Budesonide Sales Growth Rate 2020-2031 (M Units)
Figure 7. Global Budesonide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Budesonide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Budesonide Sales Market Share by Country/Region (2024)
Figure 10. Budesonide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injectable Suspension
Figure 12. Product Picture of Aerosols
Figure 13. Product Picture of Inhalation Powder
Figure 14. Product Picture of Tablet and Capsule
Figure 15. Global Budesonide Sales Market Share by Type in 2025
Figure 16. Global Budesonide Revenue Market Share by Type (2020-2025)
Figure 17. Budesonide Consumed in Respiratory Disease Treatment
Figure 18. Global Budesonide Market: Respiratory Disease Treatment (2020-2025) & (M Units)
Figure 19. Budesonide Consumed in Nose Disease Treatment
Figure 20. Global Budesonide Market: Nose Disease Treatment (2020-2025) & (M Units)
Figure 21. Budesonide Consumed in Inflammatory Bowel Disease Treatment
Figure 22. Global Budesonide Market: Inflammatory Bowel Disease Treatment (2020-2025) & (M Units)
Figure 23. Budesonide Consumed in Others
Figure 24. Global Budesonide Market: Others (2020-2025) & (M Units)
Figure 25. Global Budesonide Sale Market Share by Application (2024)
Figure 26. Global Budesonide Revenue Market Share by Application in 2025
Figure 27. Budesonide Sales by Company in 2025 (M Units)
Figure 28. Global Budesonide Sales Market Share by Company in 2025
Figure 29. Budesonide Revenue by Company in 2025 ($ millions)
Figure 30. Global Budesonide Revenue Market Share by Company in 2025
Figure 31. Global Budesonide Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Budesonide Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Budesonide Sales 2020-2025 (M Units)
Figure 34. Americas Budesonide Revenue 2020-2025 ($ millions)
Figure 35. APAC Budesonide Sales 2020-2025 (M Units)
Figure 36. APAC Budesonide Revenue 2020-2025 ($ millions)
Figure 37. Europe Budesonide Sales 2020-2025 (M Units)
Figure 38. Europe Budesonide Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Budesonide Sales 2020-2025 (M Units)
Figure 40. Middle East & Africa Budesonide Revenue 2020-2025 ($ millions)
Figure 41. Americas Budesonide Sales Market Share by Country in 2025
Figure 42. Americas Budesonide Revenue Market Share by Country (2020-2025)
Figure 43. Americas Budesonide Sales Market Share by Type (2020-2025)
Figure 44. Americas Budesonide Sales Market Share by Application (2020-2025)
Figure 45. United States Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Budesonide Sales Market Share by Region in 2025
Figure 50. APAC Budesonide Revenue Market Share by Region (2020-2025)
Figure 51. APAC Budesonide Sales Market Share by Type (2020-2025)
Figure 52. APAC Budesonide Sales Market Share by Application (2020-2025)
Figure 53. China Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 57. India Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Budesonide Sales Market Share by Country in 2025
Figure 61. Europe Budesonide Revenue Market Share by Country (2020-2025)
Figure 62. Europe Budesonide Sales Market Share by Type (2020-2025)
Figure 63. Europe Budesonide Sales Market Share by Application (2020-2025)
Figure 64. Germany Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 65. France Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Budesonide Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Budesonide Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Budesonide Sales Market Share by Application (2020-2025)
Figure 72. Egypt Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Budesonide Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Budesonide in 2025
Figure 78. Manufacturing Process Analysis of Budesonide
Figure 79. Industry Chain Structure of Budesonide
Figure 80. Channels of Distribution
Figure 81. Global Budesonide Sales Market Forecast by Region (2026-2031)
Figure 82. Global Budesonide Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Budesonide Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Budesonide Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Budesonide Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Budesonide Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Budesonide Capsules Market Growth 2025-2031
US$ 3,660.00
October 2025
89 pages
